Have a personal or library account? Click to login
Roles of Gut Microbiota and Associated Metabolites in Clostridioides difficile Infection Cover

Roles of Gut Microbiota and Associated Metabolites in Clostridioides difficile Infection

Open Access
|Jun 2025

References

  1. Amrane S, Hocquart M, Afouda P, Kuete E, Pham TP, Dione N, Ngom II, Valles C, Bachar D, Raoult D, et al. Metagenomic and culturomic analysis of gut microbiota dysbiosis during Clostridium difficile infection. Sci Rep. 2019 Sep;9(1):12807. https://doi.org/10.1038/s41598-019-49189-8
  2. Bednárik DS, Földvári-Nagy KC, Simon V, Rancz A, Gede N, Veres DS, Paraskevopoulos P, Schnabel T, Erőss B, Hegyi P, et al. Comparative effectiveness of different therapies for Clostridioides difficile infection in adults: A systematic review and network meta-analysis of randomized controlled trials. Lancet Reg Health Eur. 2025 Jan;49:101151. https://doi.org/10.1016/j.lanepe.2024.101151
  3. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015 Apr;44(2):512–525. https://doi.org/10.1093/ije/dyv080
  4. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016 May;40(4):304–314. https://doi.org/10.1002/gepi.21965
  5. Bowden J, Del Greco M F, Minelli C, Zhao Q, Lawlor DA, Sheehan NA, Thompson J, Davey Smith G. Improving the accuracy of two-sample summary-data Mendelian randomization: Moving beyond the NOME assumption. Int J Epidemiol. 2019 Jun;48(3):728–742. https://doi.org/10.1093/ije/dyy258
  6. Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR; ReproGen Consortium; Psychiatric Genomics Consortium; Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3; Duncan L, Perry JR, Patterson N, Robinson EB, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015a Nov;47(11):1236–1241. https://doi.org/10.1038/ng.3406
  7. Bulik-Sullivan BK, Loh PR, Finucane HK, Ripke S, Yang J; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Patterson N, Daly MJ, Price AL, Neale BM. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015b Mar;47(3):291–295. https://doi.org/10.1038/ng.3211
  8. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013 Nov;37(7):658–665. https://doi.org/10.1002/gepi.21758
  9. Burgess S, Timpson NJ, Ebrahim S, Davey Smith G. Mendelian randomization: Where are we now and where are we going? Int J Epidemiol. 2015 Apr;44(2):379–388. https://doi.org/10.1093/ije/dyv108
  10. Cerezo M, Sollis E, Ji Y, Lewis E, Abid A, Bircan KO, Hall P, Hayhurst J, John S, Mosaku A, et al. The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity. Nucleic Acids Res. 2025 Jan;53(D1):D998–D1005. https://doi.org/10.1093/nar/gkae1070
  11. Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, Cerani A, Liang KYH, Yoshiji S, Willett JDS, Su CY, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023 Jan;55(1):44–53. https://doi.org/10.1038/s41588-022-01270-1
  12. Choi KW, Chen CY, Stein MB, Klimentidis YC, Wang MJ, Koenen KC, Smoller JW; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Assessment of bidirectional relationships between physical activity and depression among adults: A 2-sample Mendelian randomization study. JAMA Psychiatry. 2019 Apr;76(4):399–408. https://doi.org/10.1001/jama-psychiatry.2018.4175
  13. Clemente JC, Manasson J, Scher JU. The role of the gut microbiome in systemic inflammatory disease. BMJ. 2018 Jan 8;360:j5145. https://doi.org/10.1136/bmj.j5145
  14. Cui G, Li S, Ye H, Yang Y, Jia X, Lin M, Chu Y, Feng Y, Wang Z, Shi Z, et al. Gut microbiome and frailty: Insight from genetic correlation and mendelian randomization. Gut Microbes. 2023 Dec;15(2):2282795. https://doi.org/10.1080/19490976.2023.2282795
  15. Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ. 2018 Jul;362:k601. https://doi.org/10.1136/bmj.k601
  16. Felsenstein J. Phylogenies and the comparative method. Am Nat. 1985;125(1):1–15. https://doi.org/10.1086/284325
  17. Garas LC, Cooper CA, Dawson MW, Wang JL, Murray JD, Maga EA. Young pigs consuming lysozyme transgenic goat milk are protected from clinical symptoms of enterotoxigenic Escherichia coli infection. J Nutr. 2017 Nov;147(11):2050–2059. https://doi.org/10.3945/jn.117.251322
  18. Gittleman JL, Mark K. Adaptation: Statistics and a null model for estimating phylogenetic effects. Syst Biol. 1990;(3):227–241. https://doi.org/10.2307/2992183
  19. Gu S. [Metagenomic and metabolomic approach studying the diversity of gut microbiota in patients with Clostridium difficile infection] [PhD Thesis] (in Chinese). Hangzhou (China): Zhejiang University; 2016.
  20. Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, et al; Emerging Infections Program Clostridioides difficile Infection Working Group. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med. 2020 Apr;382(14):1320–1330. https://doi.org/10.1056/nejmoa1910215
  21. Gurung B, Stricklin M, Wang S. Gut microbiota-gut metabolites and Clostridioides difficile infection: Approaching sustainable solutions for therapy. Metabolites. 2024 Jan;14(1):74. https://doi.org/10.3390/metabo14010074
  22. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018 May 30;7:e34408. https://doi.org/10.7554/eLife.34408
  23. Hobson R, Gould I, Govan J. Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media. Eur J Clin Microbiol Infect Dis. 1995 Oct;14(10):908–911. https://doi.org/10.1007/bf01691499
  24. Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022 Apr;7(1):135. https://doi.org/10.1038/s41392-022-00974-4
  25. Housworth EA, Martins EP, Lynch M. The phylogenetic mixed model. Am Nat. 2004 Jan;163(1):84–96. https://doi.org/10.1086/380570
  26. Hu X, Binxu Q, Shao GZ, Huang Y, Qiu W. Gut microbiota, circulating metabolites, and gallstone disease: a Mendelian randomization study. Front Microbiol. 2024 Jan;15:1336673. https://doi.org/10.3389/fmicb.2024.1336673
  27. Khanna S. My treatment approach to Clostridioides difficile infection. Mayo Clin Proc. 2021 Aug;96(8):2192–2204. https://doi.org/10.1016/j.mayocp.2021.03.033
  28. Konturek PC, Koziel J, Dieterich W, Haziri D, Wirtz S, Glowczyk I, Konturek K, Neurath MF, Zopf Y. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation. J Physiol Pharmacol. 2016 Dec;67(6): 859–866.
  29. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008 Apr;27(8):1133–1163. https://doi.org/10.1002/sim.3034
  30. Li XJ, Gao MG, Chen XX, Rong YM, Huang LL, Huang JS. Genetically predicted causal effects of gut microbiota and gut metabolites on digestive tract cancer: A two-sample Mendelian randomization analysis. World J Oncol. 2023 Dec;14(6):558–569. https://doi.org/10.14740/wjon1737
  31. Lopera-Maya EA, Kurilshikov A, van der Graaf A, Hu S, Andreu-Sánchez S, Chen L, Vila AV, Gacesa R, Sinha T, Collij V, et al; LifeLines Cohort Study. Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project. Nat Genet. 2022 Feb;54(2):143–151. https://doi.org/10.1038/s41588-021-00992-y
  32. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar;66(7):987–994. https://doi.org/10.1093/cid/ciy149
  33. Mirpuri J, Raetz M, Sturge CR, Wilhelm CL, Benson A, Savani RC, Hooper LV, Yarovinsky F. Proteobacteria-specific IgA regulates maturation of the intestinal microbiota. Gut Microbes. 2014 Jan–Feb;5(1):28–39. https://doi.org/10.4161/gmic.26489
  34. Mooyottu S, Flock G, Upadhyay A, Upadhyaya I, Maas K, Venkitanarayanan K. Protective effect of carvacrol against gut dysbiosis and Clostridium difficile associated disease in a mouse model. Front Microbiol. 2017 Apr;8:625. https://doi.org/10.3389/fmicb.2017.00625
  35. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012 Apr;13(9):R79. https://doi.org/10.1186/gb-2012-13-9-r79
  36. Myers TA, Chanock SJ, Machiela MJ. LDlinkR: An R Package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front Genet. 2020 Feb;11:157 https://doi.org/10.3389/fgen e.2020.00157
  37. Ng SC, Kamm MA, Yeoh YK, Chan PKS, Zuo T, Tang W, Sood A, Andoh A, Ohmiya N, Zhou Y, et al. Scientific frontiers in faecal microbiota transplantation: Joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE). Gut. 2020 Jan;69(1):83–91. https://doi.org/10.1136/gutjnl-2019-319407
  38. Ning J, Huang SY, Chen SD, Zhang YR, Huang YY, Yu JT. investigating casual associations among gut microbiota, metabolites, and neurodegenerative diseases: A Mendelian randomization study. J Alzheimers Dis. 2022;87(1):211–222. https://doi.org/10.3233/JAD-215411
  39. Normann E, Fahlén A, Engstrand L, Lilja HE. Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr. 2013 Feb;102(2):–136. https://doi.org/10.1111/apa.12059
  40. Ooi BNS, Loh H, Ho PJ, Milne RL, Giles G, Gao C, Kraft P, John EM, Swerdlow A, Brenner H, et al. The genetic interplay between body mass index, breast size and breast cancer risk: A Mendelian randomization analysis. Int J Epidemiol. 2019 Jun;48(3):781–794. https://doi.org/10.1093/ije/dyz124
  41. Pagel M. Inferring the historical patterns of biological evolution. Nature. 1999 Oct;401(6756):877–884. https://doi.org/10.1038/44766
  42. Que-Gewirth NL, Ribeiro AA, Kalb SR, Cotter RJ, Bulach DM, Adler B, Girons IS, Werts C, Raetz CR. A methylated phosphate group and four amide-linked acyl chains in Leptospira interrogans lipid A. The membrane anchor of an unusual lipopolysaccharide that activates TLR2. J Biol Chem. 2004 Jun;279(24):25420–25429. https://doi.org/10.1074/jbc.M400598200
  43. R Core Team. A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2023 [cited 2024 Oct 28]. Available from https://www.r-project.org
  44. Raina P, Wolfson C, Kirkland S, Griffith LE, Balion C, Cossette B, Dionne I, Hofer S, Hogan D, van den Heuvel ER, et al. Cohort Profile: The Canadian Longitudinal Study on Aging (CLSA). Int J Epidemiol. 2019 Dec 1;48(6):1752–1753j. https://doi.org/10.1093/ije/dyz173
  45. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes. 2011 May–Jun;2(3):145–158. https://doi.org/10.4161/gmic.2.3.16333
  46. Robinson JI, Weir WH, Crowley JR, Hink T, Reske KA, Kwon JH, Burnham CD, Dubberke ER, Mucha PJ, Henderson JP. Metabolo-mic networks connect host-microbiome processes to human Clostridioides difficile infections. J Clin Invest. 2019 Aug;129(9):3792–3806. https://doi.org/10.1172/jci126905
  47. Rudi K, Ricanek P, Tannæs T, Brackmann S, Perminow G, Vatn MH. Analysing tap-water from households of patients with inflammatory bowel disease in Norway. In: Hoorfar J, editor. Case studies in food safety and authenticity. Cambridge (UK): Woodhead Publishing Limited; 2012. p. 130–137. https://doi.org/10.1533/9780857096937.2.130
  48. Sehgal K, Khanna S. Gut microbiome and Clostridioides difficile infection: A closer look at the microscopic interface. Therap Adv Gastroenterol. 2021 Feb;14:1756284821994736. https://doi.org/10.1177/1756284821994736
  49. Shin NR, Whon TW, Bae JW. Proteobacteria: Microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015 Sep;33(9):496–503. https://doi.org/10.1016/j.tibtech.2015.06.011
  50. Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 2021 Oct;326(16):1614–1621. https://doi.org/10.1001/jama.2021.18236
  51. Sudmant PH, Rausch T, Gardner EJ, Handsaker RE, Abyzov A, Huddleston J, Zhang Y, Ye K, Jun G, Fritz MH, et al; 1000 Genomes Project Consortium. An integrated map of structural variation in 2,504 human genomes. Nature. 2015 Oct 1;526(7571):75–81. https://doi.org/10.1038/nature15394
  52. Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, Ugarte E, Muñoz-Tamayo R, Paslier DL, Nalin R, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009 Oct;11(10):2574–2584. https://doi.org/10.1111/j.1462-2920.2009.01982.x
  53. Thanissery R, Winston JA, Theriot CM. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids. Anaerobe. 2017 Jun;45:86–100. https://doi.org/10.1016/j.anaer-obe.2017.03.004
  54. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013 Jan;368(5):407–415. https://doi.org/10.1056/NEJMoa1205037
  55. van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B, Krutova M, Norén T, Allerberger F, Coia JE, et al; Guideline Committee of the European Study Group on Clostridioides difficile. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021 Dec;27(Suppl_2):S1–S21. https://doi.org/10.1016/j.cmi.2021.09.038
  56. Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018 May;50(5):693–698. https://doi.org/10.1038/s41588-018-0099-7
  57. Vliex LMM, Penders J, Nauta A, Zoetendal EG, Blaak EE. The individual response to antibiotics and diet – insights into gut microbial resilience and host metabolism. Nat Rev Endocrinol. 2024 Jul;20(7):387–398. https://doi.org/10.1038/s41574-024-00966-0
  58. Voronina OL, Kunda MS, Ryzhova NN, Aksenova EI, Semenov AN, Lasareva AV, Amelina EL, Chuchalin AG, Lunin VG, Gints-burg AL. The variability of the order Burkholderiales representatives in the healthcare units. Biomed Res Int. 2015;2015:680210. https://doi.org/10.1155/2015/680210
  59. Wang Q, Dai H, Hou T, Hou Y, Wang T, Lin H, Zhao Z, Li M, Zheng R, Wang S, et al. Dissecting Causal Relationships Between Gut Microbiota, Blood Metabolites, and Stroke: A Mendelian Randomization Study. J Stroke. 2023 Sep;25(3):350–360. https://doi.org/10.5853/jos.2023.00381
  60. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012 Feb;6(2):320–329. https://doi.org/10.1038/ismej.2011.109
  61. Wickham H, Averick M, Bryan J, Chang W, McGowan L, François R, Grolemund G, Hayes A, Henry L, Hester J, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4(43):1686. https://doi.org/10.21105/joss.01686
  62. Wickham H. ggplot2: Elegant graphics for data analysis. New York (USA): Springer International Publishing; 2016. https://doi.org/10.1007/978-3-319-24277-4
  63. Wielscher M, Amaral AFS, van der Plaat D, Wain LV, Sebert S, Mosen-Ansorena D, Auvinen J, Herzig KH, Dehghan A, Jarvis DL, Jarvelin MR. Genetic correlation and causal relationships between cardio-metabolic traits and lung function impairment. Genome Med. 2021 Jun;13(1):104. https://doi.org/10.1186/s13073-021-00914-x
  64. Winston JA, Rivera AJ, Cai J, Thanissery R, Montgomery SA, Patterson AD, Theriot CM. Ursodeoxycholic acid (UDCA) mitigates the host inflammatory response during Clostridioides difficile infection by altering gut bile acids. Infect Immun. 2020 May;88(6):e00045-20. https://doi.org/10.1128/IAI.00045-20
  65. Xiang K, Wang P, Xu Z, Hu YQ, He YS, Chen Y, Feng YT, Yin KJ, Huang JX, Wang J, et al. Causal effects of gut microbiome on systemic lupus erythematosus: A two-sample Mendelian randomization study. Front Immunol. 2021 Sep;12:667097. https://doi.org/10.3389/fimmu.2021.667097
  66. Xu Q, Ni JJ, Han BX, Yan SS, Wei XT, Feng GJ, Zhang H, Zhang L, Li B, Pei YF. Causal relationship between gut microbiota and autoimmune diseases: A two-sample Mendelian randomization study. Front Immunol. 2022 Jan;12:746998. https://doi.org/10.3389/fimmu.2021.746998
  67. Zhao M, Ma J, Liu H, Luo Y, Deng H, Wang D, Wang F, Zhang P. The gut microbiota contributes to systemic responses and liver injury in gut-derived sepsis. Microorganisms. 2023 Jul;11(7):1741. https://doi.org/10.3390/microorganisms11071741
  68. Zhou J, Fan Q, Cai X, Zhang Y, Hou Y, Cao S, Li Z, Feng M, Wang Q, Zhang J, Wang G, Zheng X, Hao H. Ginkgo biloba extract protects against depression-like behavior in mice through regulating gut microbial bile acid metabolism. Chin J Nat Med. 2023 Oct;21(10):745–758. https://doi.org/10.1016/s1875-5364(23)60496-0
DOI: https://doi.org/10.33073/pjm-2025-017 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 206 - 217
Submitted on: Dec 31, 2024
Accepted on: Apr 25, 2025
Published on: Jun 18, 2025
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 YAN GAO, JINGXIN MA, KEDI WANG, KAIHUI MA, WEN ZHAO, JIANRONG SU, LIYAN MA, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.